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Abstract: Three stable dinuclear zinc(II) complexes, [Zn2L1(-NO3)(NO3)2] and [Zn2L1(-
OMe)(NO3)2], where L1 is 2,6-bis{[N-(2-dimethylaminoethyl)-N-methyl]-aminomethyl}-4-
methylphenolate, and [Zn2L2(NO3)3], where L2 is 2-{[N-(2-dimethylaminoethyl)-N-methyl]-
aminomethyl}-4-bromo-6-{[N’-2-( 2’-pyridyl)-ethyl]-aminomethyl}phenolate, were synthe-
sized and characterized in the solid state and in aqueous solution. These complexes cata-
lyze the hydrolysis of penicillin G and nitrocefin, serving as functional synthetic analogues 
of the metallo--lactamases, bacterial enzymes responsible for antibiotic resistance. The 
mechanism of the hydrolysis was studied in detail for the catalyst precursor [Zn2L1(-
NO3)(NO3)2], which converts into [Zn2L1(-OH)(NO3)n(sol)2-n](2-n)+ in aqueous solution. 
The complex [Zn2L1(-OH)(NO3)2] (n=2) was characterized in the solid state. Initial coor-
dination of the substrate carboxylate group is followed by the rate-limiting nucleophilic 
attack of the bridging hydroxide at the -lactam carbonyl group. The product is formed 
upon fast protonation of the intermediate. Mononuclear complexes [Zn(cyclen)](OTf)2 and 
[Zn(bpta)](OTf)2 are as reactive in the -lactam hydrolysis as the dinuclear complexes. 
Consequently, the second zinc ion is not required for catalytic activity.  
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Introduction 
 Approximately half of the commercially available antibiotics are -lactams.[Neu, 
1992 #3] In recent years, bacterial resistance to a wide range of antibiotics has become so 
prevalent that some infections can no longer be successfully treated.[Massova, 1997 #1; 
Neu, 1992 #3; Cohen, 1992 #2] A common reason for resistance to -lactam antibiotics in 
bacteria is their ability to express -lactamases, enzymes that catalyze the hydrolytic open-
ing of the -lactam ring, as depicted in eq  1 for the penicillin deri- 
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derivatives. Unlike the parent -lactam, the hydrolysis product does not interfere with cell 
wall biosynthesis and is therefore harmless to bacteria. The high periplasmic concentra-
tions of -lactamases, in addition to their efficiency, assure that -lactam antibiotic drugs 
are hydrolyzed before reaching their targets.[Hechler, 1989 #7]   
 Among the more than 200 -lactamases that have been identified to date[Bush, 1995 
#8] the majority (>90 %) share an active-site serine residue and are collectively termed ser-
ine -lactamases. Their well-studied mechanism involves nucleophilic attack of the serine 
hydroxyl group at the -lactam carbonyl group, followed by hydrolysis of the acyl-enzyme 
intermediate.[Page, 1998 #6] In contrast, the less abundant class B -lactamases require di-
valent metal ions for catalytic activity.[Page, 1998 #6; Davies, 1974 #9] Since only 18 of the 
many characterized -lactamases are metallo--lactamases, the clinical threat imposed by 
these enzymes was initially underestimated.[Rasmussen, 1997 #10; Walsh, 1996 #11] 
Metallo--lactamases can hydrolyze a wide range of substrates, however, including 
cephamycins and imipenem, compounds resistant to the serine -lactamases.[Bush, 1998 
#12; Livermore, 1998 #57] Moreover, the metalloenzymes show little or no susceptibility to 
traditional -lactamase inhibitors, such as clavulanic acid or sulbactam. Although there 
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have been reports of molecules that inhibit metallo--lactamases, at present there are no 
clinically useful inhibitors.[Hammond, 1999 #58; Toney, 1998 #60] Thus, the application of 
most available antibiotics has been severely compromised in bacteria that produce 
metallo--lactamases.  
 Most metallo--lactamases are monomers containing a single polypeptide chain 
composed of 220-230 residues.[Page, 1998 #6] Crystal structures are available for several 
enzymes in this class, from Bacteroides fragilis, Bacillus cereus II, and most recently from 
Stenotrophomonas maltophilia.[Concha, 1996 #14; Ullah, 1998 #13; Fabiane, 1998 #15; Carfi, 
1995 #16] Whereas the sequences of the first two enzymes are conserved (50 residues), the 
S. maltophilia enzyme has only 9 conserved amino acids. B. fragilis  and B. cereus II -
lactamases have similar dizinc-binding motifs that include one cysteine, three histidine, 
and one aspartate residues. In the S. maltophilia  -lactamase, the cysteine residue is re-
placed by serine, resulting in the coordination of a second histidine to Zn(2). The struc-
tures are represented in Scheme 1.[Bush, 1998 #12] The stability constants for the two zinc-
binding sites differ, and -lactamases have been isolated with only one zinc site occu-
pied.[Paul-Soto, 1998 #17; Paul-Soto, 1999 #61] All three enzymes have a hydroxide ion 
that either bridges the two zinc(II) ions, as in the S. maltophilia  and B. fragilis  enzymes, or 
is coordinated to Zn(1) as in the B. cereus II -lactamase. In the latter case, an aspartate car-
boxylate group serves to link the two zinc(II) ions. The enzymes all have either lysine or 
serine residues at the active site. Hydrogen bonding between these residues and the con-
served carboxylate group present in the antibiotics is postulated to position the substrate 
as indicated in Scheme 1. 
The mechanism of action for class B -lactamases has not been fully elucidated. By 
analogy with other metallohydrolases such as carboxypeptidase, catalysis is postulated to 
involve attack of a metal-bound hydroxide on the carbonyl group of the -lactam ring fol-
lowed by collapse of the tetrahedral intermediate.[Concha, 1996 #14] Such a process seems 
inconsistent with the measured pH-independence of kcat and kcat/Km in the range 5.25-
10.0,[Wang, 1998 #69] however, since both attack by hydroxide ion and protonation of the 
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departing nitrogen atom should be sensitive to pH. Perhaps the pKa values are outside the 
measured range. More likely the pH-independence of kcat arises from the opposing pH ef-
fects on the nucleophilic attack and protonation, the two steps that contribute to kcat. Re-
cent reports suggest that cleavage of the amide bond occurs before protonation, with the 
resulting anionic intermediate being stabilized by coordination to zinc(II).[Wang, 1999 #67; 
Wang, 1998 #68] Protonation of this species is the rate-determining step. Site-directed-
mutagenesis studies suggest that Asp-90, in -lactamase from B. cereus, may serve such a 
role as a general acid.[Lim, 1991 #19] Despite this information, it is still uncertain whether 
hydrolysis occurs by general-base catalysis or whether zinc provides a local source of hy-
droxide ion. The possibility that the antibiotic carboxylate group may coordinate directly 
to zinc ions,[Wang, 1999 #67] and the role of zinc bound in the second metal-binding site, 
have not been adequately addressed.  
Because of the complexity of the enzyme, synthetic model compounds offer the po-
tential to contribute mechanistic insights. Such information would both be of fundamental 
interest and could help in the design of mechanism-based inhibitors. With these objectives 
in mind, we have prepared three water-stable dinuclear zinc(II) complexes of ligands HL1 
and HL2 (Scheme 2) and have evaluated them as functional -lactamase models for the 
hydrolysis of -lactam antibiotics. The -lactam hydrolytic reactivity of mononuclear ana-
logues, formed by ligands L3 and L4, was also determined and compared to that of the 
dinuclear compounds. 
 
Experimental Section 
 Chemicals. Deuterated compounds D2O, DMSO-d6, acetone-d6, chloroform-d1, and 
dichloromethane-d2 were obtained from Cambridge Isotope Laboratories. Starting materi-
als and reagents Zn(NO3)2. 6H2O, Zn(OTf)2, 2-(2-aminoethyl)pyridine, N,N,N’-
trimethylethylenediamine, p-cresol, NaBH4, 5-bromosalicylaldehyde, and cyclen were ob-
tained from Aldrich. Succinic acid disodium salt hexahydrate, LiOH.H2O, and a 0.100 M 
standard solution of NaOH were obtained from Fluka. Alanine, penicillin G (sodium salt), 
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and cephalothin (sodium salt) were obtained from Sigma. The hydrolytic substrate 
nitrocefin (2-(2,4-dinitrostyryl)-(6R,7R)-7-(2-thienylacetamide)-ceph-3-em-4-carboxylic ac-
id, E isomer) was kindly donated by Merck. These and all other chemicals were of reagent 
grade. 
 Physical Measurements.  1H and 13C NMR spectra were obtained at 500 and 125 
MHz, respectively, on Varian 500 and 501 NMR spectrometers. UV-visible spectra were 
recorded on a Cary 1E spectrophotometer equipped with a temperature-controlled unit. 
Solution IR spectra were recorded on a Biorad FTS-135 FTIR spectrometer between 400 
and 4000 cm-1 using CaF2 cells at room temperature. 
 Ligand Syntheses. Reactions were carried out under an atmosphere of dinitrogen. 
The ligand HL1 was synthesized according to a published procedure.[Higuchi, 1995 #20] 
The mixture of p-cresol (5.50 g, 50 mmol), N,N,N’-trimethylethylenediamine (10.20 g, 100 
mmol) and paraformaldehyde (4.00 g, 134 mmol) was refluxed in ethanol (150 mL) for 8.5 
h. Upon cooling to room temperature, the reaction mixture was acidified with 15 mL of 
48% HBr. The solution was then evaporated to dryness to give a yellow oil. Dissolution in 
ethanol yielded 2,6-bis{[N-(2-dimethylaminoethyl)-N-methyl]-aminomethyl}-4-
methylphenol trihydrobro-mide as a white precipitate that was filtered off and dried un-
der vacuum. Yield: 16.50 g (57%). 1H NMR in D2O:  6.86 s (2H), 3.78 t (4H), 3.23 t (4H), 
2.92 t (4H), 2.60 s (12H), 2.31 s (6H), 1.96 s (3H). Calc. for C19H39N4O1: C, 39.40; H, 6.79; N, 
9.67. Found: C, 39.59; H, 6.86; N, 9.23. The neutral ligand was obtained as a colorless oil by 
neutralizing the trihydrobromide salt with NaHCO3. The ligand HL2 was synthesized by a 
modification of a published procedure, as shown in Scheme S1 (Supporting Infor-
mation).[Crane, 1991 #21] In the first step, a mixture of 5-bromosalicylaldehyde (11.24 g, 
56 mmol), N,N,N’-trimethylethyle-nediamine (4.80 g, 47 mmol) and paraformaldehyde 
(2.73 g, 88 mmol) was refluxed in ethanol (150 mL) for 20 h then cooled to room tempera-
ture. Addition of the first 4-5 mL of hydrobromic acid (48%) to the resulting yellow solu-
tion turned the solution cloudy; when the total amount of 48% HBr (16.8 mL) was added a 
white precipitate, 3-{[N-(2-dimethylaminoethyl)-N-methyl}-aminomethyl]-5-bromosalicyl-
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aldehyde dihydrobromide, appeared. The precipitate was filtered, washed with EtOH, 
and dried under vacuum. The filtrate was evaporated to dryness to give a yellow-white 
solid. Addition of 150 mL EtOH to this solid resulted in the formation of more white pre-
cipitate that was filtered, washed with EtOH, and dried under vacuum. The overall yield 
was 19.5 g (87%). 1H NMR in D2O:  9.82 s (1H), 8.05 s (1H), 7.90 s (1H), 4.40 s (2H), 3.5 m 
(4H), 2.94 s (6H), 2.87 (3H). The neutral compound was obtained as a colorless oil by neu-
tralizing the dihydrobromide salt (5.00 g, 10 mmol) with NaHCO3 (2.20 g, 26 mmol) in 
aqueous solution. The solution was then extracted twice (2 x 100 mL) with dichloro-
methane. The combined CH2Cl2 layers were dried over Na2SO4 and evaporated to dryness 
to give a bright yellow solid. Yield: 2.80 g (89%). 1H NMR in CD2Cl2:  10.30 s (1H), 7.63 s 
(1H), 7.23 s (1H), 3.40 s (2H), 2.50 m (4H), 2.21 s (6H), 2.15 s (3H). In the second step, 3-[{N-
(2-dimethylaminoethyl)-N-methyl}-aminomethyl]-5-bromosalicyl-aldehyde (2.80 g, 8.9 
mmol) was heated for 20 min (313-323 K) in methanol to allow complete dissolution, and 
then 2-(2-aminoethyl)pyridine (1.06 mL, 8.9 mmol) was added. The solution was allowed 
to cool to room temperature and stirred overnight. The solvent was then removed by rota-
ry evaporation to give yellow oil 3-{[N-(2-dimethylaminoethyl)-N-methyl]-aminomethyl}-
5-bromo-N’-{2-(2’-pyridyl)-ethyl}salicy-limine as a product. Yield: 1.87 g (50%). 1H NMR in 
CD2Cl2:  8.40 br (1H), 8.20 br (2H), 7.50 t (1H), 7.38 d (1H), 7.20 d (1H), 7.05 t (1H), 3.06 t 
(2H), 3.92 t (2H), 3.42 s (2H), 2.40 t (2H), 2.32 t (2H), 2.13 s (3H), 2.10 s (6H). In the third 
step, the imine compound (3.50 g, 8.3 mmol) was reduced by addition of NaBH4 (0.32 g, 
8.5 mmol) in methanol (200 mL). The mixture was stirred at room temperature for 24 h. 
The pH of this solution was adjusted to 2 with 4.0 M HCl and then to 9 with 2.0 M NaOH. 
The methanol portion was removed by rotary evaporation and the remaining aqueous part 
was extracted twice (2 x 100 mL) with dichloromethane. The CH2Cl2 layers were collected, 
dried over Na2SO4, and the solvent was removed to give a yellow oil 2-{[N-( 2-
dimethylaminoethyl)-N-methyl]-aminomethyl}-4-bromo-6-{[N’-2-( 2’-pyridyl)-ethyl]-
aminomethyl}phenol as a product. Yield: 2.95 g (84%). 1H NMR in 1:1 D2O:DMSO-d6 :  
8.45 s (1H), 7.80 t (1H), 7.35 br (2H), 7.21 s (1H), 7.17 s (1H), 3.79 s (2H), 3.60 s (2H), 2.95 m 
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(4H), 2.65 br (4H), 2.30 s (6H), 2.28 s (3H). The ligand N,N-bis(2-pyridylmethyl)tert-
butylamine (bpta) was synthesized as described previously.[Mok, 1997 #23]  
 Zinc Complexes. 
[Zn2L1(-NO3)(NO3)2]. The ligand HL1 (0.035 g, 0.105 mmol) in ethanol (1.5 mL) and 
LiOH.H2O (0.004 g, 0.105 mmol) in H2O (0.2 mL) were mixed and stirred at room tempera-
ture for 10 min. Then a solution of Zn(NO3)2.6H2O (0.062 g, 0.210 mmol) in ethanol (1.5 
mL) was added. The initially clear reaction mixture turned milky upon stirring and after 
30 min the product [Zn2L1(-NO3)(NO3)2] appeared as a white precipitate. It was filtered 
off and dried under vacuum. The yield was 0.048 g (70%). 1H NMR in D2O:  6.96 s (2H), 
4.25 d (2H), 3.32 d (2H), 2.80 m (8H), 2.50 s (12H), 2.35 s (3H), 2.12 s (6H), for RR and SS 
isomers; and 6.95 s (2H), 4.00 br (2H), 3.60 br (2H), 2.80 m (8H), 2.50 s (12H), 2.45 s (3H), 
2.15 s (6H), for RS and SR isomers. Layering a solution of HL1 (0.035 g, 0.210 mmol) and 
LiOH.H2O (0.004 g, 0.105 mmol) in ethanol (1.5 mL) : H2O (0.2 mL) with a solution of 
Zn(NO3)2.6H2O (0.062 g, 0.105 mmol) in ethanol (1.5 mL) without stirring afforded color-
less crystals of [Zn2L1(-NO3)(NO3)2] that were suitable for X-ray analysis. 1H NMR in 
D2O:  6.96 s (2H), 4.26 d (2H), 3.32 d (2H), 2.80 m (8H), 2.51 s (12H), 2.32 s (3H), 2.15 s 
(6H), for RR and SS isomers; and 6.95 s (2H), 4.00 br (2H), 3.60 br (2H), 2.80 m (8H), 2.50 s 
(12H), 2.41 s (3H), 2.15 s (3H), for RS and SR isomers. Calc. for C19H35N7O10Zn2: C, 34.99; 
H, 5.41; N, 15.03. Found: C, 34.95, 35.10, 35.05; H, 5.54, 5.58, 5.62; N, 14.57, 14.58, 14.58. The 
single crystal of [Zn2L1(-OH)(NO3)2] identified by X-ray crystallography (vide infra) was 
obtained as a very minor component by using the same crystallization procedure.  
[Zn2L1(-OMe)(NO3)2]. A procedure similar to that described for preparing 
[Zn2L1(-NO3)(NO3)2] but using neat methanol as the solvent afforded the methoxide 
complex [Zn2L1(-OMe)(NO3)2] in 65% yield. 1H NMR in DMF-d7:  6.92 s (2H), 4.18 br 
(2H), 3.62 s (3H), 3.50 br (2H), 2.95 m (4H), 2.50 m (19H), 2.20 s (6H), for RS and SR iso-
mers; and 6.90 s (2H), 4.35 d (2H), 3.60 s (3H), 3.40 d (2H), 2.95 m (4H), 2.60 m (4H), 2.50 m 
(15H), 2.20 s (6H), for RR and SS isomers. 1H NMR in chloroform-d1:  6.78 s (2H), 4.45 d 
(2H), 3.50 s (3H), 3.25 d (2H), 2.90 m (4H), 2.30-2.60 m (25H), for RR and SS isomers. Layer-
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ing solutions of L1- and Zn(NO3)2, as described for [Zn2L1(-NO3)(NO3)2], in neat methanol 
afforded [Zn2L1(-OMe)(NO3)2] as colorless crystals in 50% yield. Calc. for C20H38N6O8Zn2: 
C, 38.66; H, 6.16; N, 13.53. Found: C, 38.44; H, 6.37; N, 13.77. 1H NMR in D2O:  6.97 s 
(2H), 4.25 d (2H), 3.32 d (2H), 2.80 m (8H), 2.51 s (12H), 2.32 s (3H), 2.15 s (6H), for RR and 
SS isomers; and 6.95 s (2H), 3.98 br (2H), 3.60 br (2H), 2.80 m (8H), 2.50 s (12H), 2.41 s 
(3H), 2.15 s (3H), for RS and SR isomers; methoxide group is not observed; 3.30 s (free 
MeOH). 
[Zn2L2(NO3)3]. The ligand HL2 (0.044 g, 0.104 mmol) in ethanol (2.0 mL) and 
LiOH.H2O (0.004 g, 0.105 mmol) in H2O (0.15 mL) were mixed and stirred at room tem-
perature for 10 min. Then Zn(NO3)2.6H2O (0.062 g, 0.105 mmol) in ethanol (3.0 mL) was 
added without stirring. Upon standing at room temperature, the product [Zn2L2(NO3)3] 
appeared as light-yellow crystals suitable for X-ray analysis. They were filtered off and 
dried under vacuum; yield: 0.031 g (40%). Calc. for C20H28BrN7O10Zn2: C, 32.59; H, 3.83; N, 
13.30. Found: C, 32.65; H, 4.07; N, 13.15. 1H NMR in 1:1 D2O:DMSO-d6:  8.65 br (1H), 8.48 
br (1H), 7.91 br d (1H), 7.49 br d (1H), 7.39 t (1H), 7.31 t (1H), 4.18 br (1H), 3.96 br (1H), 3.35 
br (1H), 3.20 br (1H), 2.5 br (12H), 2.29 br (6H), 2.27 br (3H).  
Mononuclear Complexes. The two mononuclear complexes [Zn(cyclen)(H2O)]2+ 
and [Zn(bpta)(H2O)]2+ were prepared in situ by mixing equivalent amounts of the corre-
sponding ligand and Zn(NO3)2·6H2O. 
 X-Ray Crystallography.  X-ray crystallographic studies were carried out on a 
Bruker CCD diffractometer with graphite-monochromatized Mo K radiation ( = 0.71073 
Å) controlled by a pentium-based PC-running the SMART software package.[, 1998 #25] 
Single crystals were mounted at room temperature on the ends of glass fibers in Paratone 
N oil, and data were collected at 188 K in a steam of cold dinitrogen maintained by a 
Bruker LT-2A nitrogen cryostat. Data collection and reduction protocols are described in 
detail elsewhere.[Feig, 1996 #26] The structures were solved by direct methods and refined 
using the SHELXTL software package.[Sheldrick, 1997 #27] In general, all non-hydrogen 
atoms were refined anisotropically. Hydrogen atoms were assigned idealized locations. 
  
9
Empirical absorption corrections were applied to all structures using SADABS.[Sheldrick, 
1997 #27] The ethylene and the two methyl groups of the terminal amine nitrogen and the 
two oxygen atoms of monodentate nitrate in [Zn2L2(NO3)3] are disordered. The carbon at-
oms were distributed over the two sets of positions and refined with occupancy factors of 
0.71 and 0.29. The two oxygen atoms of the monodentate nitrate were distributed over two 
sets of positions and refined with occupancy factors of 0.6 and 0.4. Relevant crystallo-
graphic information is summarized in Tables 1 and 2, Tables S1-S16 and Fig. 1 and Figs. 
S1-S4. 
 Potentiometric pH Titrations.  All titration experiments were performed on a 
Brinkmann 176 DMS Titrino instrument equipped with a magnetic stirrer and an automat-
ic pipette. The temperature was measured before and after each experiment and remained 
constant at a value of 296  0.5 K. The ionic strength of 0.10 M was adjusted with NaNO3. 
A fresh 0.1 M solution of NaOH calibrated against potassium hydrogen phthalate was 
used as received to prepare a 0.01 M titrating solution, which was stored under NaOH pel-
lets in Brinkmann 176 DMS Titrino instrument and used within one or two days. Acid 
deprotonation constants for the aqua ligands were determined by titrating each com-
plex. In a typical experiment, a 1.0 x 10-5 mol portion of a complex was dissolved in 10 mL 
of aqueous 0.10 M NaNO3. Usually standard 0.0958 N HNO3 was added to protonate the 
bridging hydroxide. Then, after 2 min equilibration, a titration experiment was initiated. 
Experimental data were fit by using the program PKAS to obtain the pKa values.[Martell, 
1988 #28] Titration experiments were repeated three times for each of the complexes and 
the reported pKa values are the averages of these triplicate runs. The potentiometric pH 
titrations of HL13HBr in the presence and absence of Zn(NO3)2·6H2O were carried out 
to determine ligand protonation constants (Kn), zinc(II) complexation constant (KZn2L), 
and deprotonation constants for the zinc(II) complex (Kph, Ka1, Ka2). The equilibrium 
constants are defined in eqs 2-6. Typically 1.0 x 10-5 mol portion of HL13HBr was dis-
solved 
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Hn-1HL1 + H+  =  HnHL1                           Kn = [HnHL1]/[Hn-1HL1][H+] (2) 
HL1  +  2Zn(II)  =  Zn2HL1                        KZn2L = [Zn2HL1]/[HL1][Zn(II)]2 (3) 
Zn2HL1  =  Zn2L1  +  H+                             Kph = [Zn2L1][H+]/[Zn2HL1] (4) 
Zn2L1(-H2O)  =  Zn2L1(-OH)   +  H+    Ka1 = [Zn2L1(-OH)][H+]/[ Zn2L1(-H2O)] (5) 
Zn2L1(-OH)(H2O)  =  Zn2L1(-OH)(OH)   +  H+  
                                                         Ka2 = [Zn2L1(-OH)(H2O)][H+]/[ Zn2L1(-OH)(OH)] 
(6) 
 
 in 10 mL of a queous 0.10 M NaNO3, followed by optional addition of 2.0 x 10-5 mol 
portion of Zn(NO3)2·6H2O. After 10 min equilibration the titration experiment was 
started. Experimental data were fit using the program BEST.[Martell, 1988 #28] The val-
ue pKW was -13.78. Inclusion of equilibria that contain mononuclear zinc(II) species 
does not affect fits. Each titration was repeated two times and the reported values of the 
equilibrium constants are the averages of these duplicate runs. The deprotonation con-
stants do not change significantly upon addition of 10% DMSO to the aqueous solu-
tions.[Bates, 1963 #75] 
 Stability of Dinuclear Complexes in Water.  The composition of the complexes in 
aqueous solution was studied by 1H NMR titration experiments at 293 K. The solvent was 
D2O for experiments with HL1, and a 1:1 mixture of D2O:DMSO-d6 in experiments with 
HL2. The initial concentrations of ligands were determined by comparison with added Ala 
as an internal standard. The initial concentrations of HL1 and HL2, were 0.0640 and 0.0383 
M, respectively. In each set of the titration experiments, aliquots of the titrating solutions 
were added to the NMR tube containing the ligand solution. After each addition, a 1H 
NMR spectrum was taken. In HL1 titration experiments, an aliquot of a 1.00 M solution of 
Zn(NO3)2.6H2O in D2O was added first into the NMR tube, followed by the addition of an 
aliquot of 1.00 M LiOH.H2O in D2O. In HL2 titration experiments the same composition of 
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the titrating solutions was used but with a 1:1 mixture of D2O:DMSO-d6 as the solvent. The 
concentrations of the ligand and of the complex in the HL1  titrations were determined 
from the respective integral areas, with an estimated error of 5-10%. Because the peaks 
were too broad in the HL2 titration experiments owing to exchange, the integration was 
not performed. Instead, the downfield shift of the 1H resonance at 3.79 ppm was followed 
for the methylene protons in the pyridine arm after each added aliquot of Zn(II) and base. 
Dilution of 0.04 M solutions of [Zn2L1(-NO3)(NO3)2] and [Zn2L2(NO3)3] 10-70 fold did 
not result in changes in 1H NMR spectra. 
 Penicillin G Methyl Ester.  The ester was synthesized from the sodium salt of peni-
cillin G (5.0 g, 14 mmol) and methyl iodide (1.746 mL, 29.4 mmol) in DMF (60 mL) at room 
temperature. After 16 h of stirring the solvent was removed under reduced pressure to 
give a pale yellow oil. This oil was then washed with water (100 mL) and acetone (10 mL). 
Removal of the solvents followed by drying under vacuum afforded penicillin G methyl 
ester as a white solid in 50% yield (2.4 g). 1H NMR in CDCl3:  7.30 m (5H), 6.25 d (1H), 
6.61 dd (1H), 5.47 d (1H), 4.35 s (1H), 3.70 s (3H), 3.60 s (2H), 1.42 s (3H), 1.40 s (3H). 13C 
NMR in 1:1 D2O:DMSO  174.2 (C(O)N), 170.9 (C(O)N-lactam), 168.5 (COO), 136.4, 129.6, 
128.6, 126.9, 70.6, 68.1, 64.5, 59.2, 52.5, 42.0, 30.6, 26.9. 
 Binding of Substrates to Zn(II).  Binding Studies in the Absence of Water. 13C NMR 
spectroscopic experiments were carried out and the chemical shifts are given in ppm rela-
tive to DMSO-d6 as an internal reference. In each experiment, the solution was initially 0.15 
M in complex and 0.15 M in penicillin G sodium salt or cephalothin. The solvent was a 1:1 
mixture of acetone-d6:DMSO-d6 or pure DMSO-d6 in experiments investigating the binding 
of penicillin G and DMSO-d6 for work with cephalothin. The temperature was always 293 
K. 13C NMR in 1:1 acetone-d6:DMSO-d6 for free penicillin G:  174.4 (C(O)N-lactam), 171.7 
(COO), 170.6 (C(O)N), 136.4, 129.4, 128.3, 126.6, 74.2, 67.1, 64.5, 57.8, 41.7, 30.8, 27.6. 13C 
NMR in DMSO-d6 for free penicillin G (carbonyl region):  173.8 (C(O)N-lactam), 170.9 
(COO), 170.6 (C(O)N). 13C NMR in 1:1 acetone-d6:DMSO-d6 for free cephalothin:  174.4 
(ester), 173.7 (C(O)N), 167.9 (COO), 165.3 (C(O)N-lactam), 137.4, 133.5, 128.0, 128.5, 126.9, 
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116.6, 65.6, 60.1, 58.4, 37.4, 26.5, 21.9. 13C NMR in DMSO-d6 for free cephalothin (carbonyl 
region):  170.6 (ester), 170.0 (C(O)N), 164.3 (COO), 163.1 (C(O)N-lactam). 13C NMR in 1:1 
acetone-d6:DMSO-d6 for penicillin G in the presence of [Zn2L1(-NO3)(NO3)2] (carbonyl re-
gion):  174.2 (C(O)N-lactam), 174.1 (COO), 170.8 (C(O)N). 13C NMR in DMSO-d6 for peni-
cillin G in the presence of Zn(cyclen)(OTf)2 (carbonyl region):  173.7 (C(O)N-lactam), 
172.3 (COO), 170.6 (C(O)N). 13C NMR in DMSO-d6 for penicillin G in the presence of 
Zn(bpta)(OTf)2 (carbonyl region):  173.3 (C(O)N-lactam), 172.8 (COO), 170.8 (C(O)N).13C 
NMR in DMSO-d6 for cephalothin in the presence of [Zn2L1(-NO3)(NO3)2] (carbonyl re-
gion):  170.7 (ester), 170.4 (C(O)N), 166.9 (COO), 165.1 (C(O)N-lactam). 13C NMR in 
DMSO-d6 for cephalothin in the presence of Zn(cyclen)(OTf)2 (carbonyl region):  170.6 (es-
ter), 170.2 (C(O)N), 166.5 (COO), 164.3 (C(O)N-lactam). 13C NMR in DMSO-d6 for 
cephalothin in the presence of Zn(bpta)(OTf)2 (carbonyl region):  170.4 (ester), 170.2 
(C(O)N), 166.9 (COO), 164.1 (C(O)N-lactam). 
In a typical solution IR spectroscopic experiment, the initial concentrations of com-
plex and substrate (sodium salt of penicillin G or cephalothin) were 0.05 M each and the 
solvent was always DMSO. IR (cm-1) for free penicillin G sodium salt in carbonyl region: 
1621 (asym(COO)), 1677 (C(O)N), 1767 (C(O)-lactam). Penicillin G in the presence of 
[Zn2L1(-NO3)(NO3)2]: 1638 (asym(COO)), 1677 (C(O)N), 1777 (C(O)-lactam). Penicillin G in 
the presence of Zn(bpta)(OTf)2: 1632 and 1642 (asym(COO)), 1677 (C(O)N), 1775 (C(O)-
lactam). Free cephalothin: 1617 (asym(COO)), 1680 (C(O)N), 1731 (ester), 1773 (C(O)-
lactam). Cephalothin in the presence of [Zn2L1(-NO3)(NO3)2]: 1630 (asym(COO)), 1682 
(C(O)N), 1734 (ester), 1777 (C(O)-lactam). IR for penicillin G methyl ester: 1677 (C(O)N), 
1750 (C(O)-lactam), 1783 (COOMe). 
Binding in Aqueous Solution.  The sodium salt of cephalothin G (30.0 mg, 0.07 
mmol) and the complex [Zn2L1(-NO3)(NO3)2] (45.6 mg, 0.07 mmol) were respectively 
dissolved in two aqueous solutions containing 10% DMSO (1.0 mL each). Mixing these 
two solutions resulted in immediate appearance of the fluffy white precipitate 
[Zn2L1(cephalothin)(NO3)2]. The reaction mixture was stirred for additional 2 h at room 
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temperature. The precipitate was filtered out, washed with water, and dried in vacuo. 
13C NMR in DMSO-d6 (carbonyl region):  170.7 (ester), 170.3 (C(O)N), 166.9 (COO), 
165.1 (C(O)N-lactam). Mixing experiments in pure water and in a 1:1 mixture of water 
and DMSO gave identical results. 
 Hydrolysis of Penicillin G and Penicillin G Methyl Ester.  These reactions were 
studied by 1H NMR spectroscopy. The solvent was a 1:1 mixture of D2O and acetone-d6 
and the temperature was 313 K. The initial concentrations of [Zn2L1(-NO3)(NO3)2] and a 
substrate (penicillin G, sodium salt; and penicillin G, methyl ester) were 0.025 M each. 
Substrate hydrolysis was followed by monitoring the C(5)-H and C(6)-H resonances at 4.96 
and 4.46 ppm in (5R)-penicilloic acid and at 5.10 and 4.50 ppm in (5R)-penicilloic acid-1-
methyl ester. 
Kinetics of Hydrolysis. The kinetics of substrate hydrolysis was followed by UV-
visible spectrophotometry. The temperature inside the cuvettes was measured directly 
with a thermocouple. The solvent was either a 9:1 mixture of 0.05 M HEPES buffer and 
DMSO or a 9:1 mixture of acetone and DMSO. The reported pH values of the solutions 
correspond to the aqueous component. The substrate used for the kinetic studies was 
nitrocefin. Its extinction coefficient () at 390 nm was determined by measuring the ab-
sorbance of solutions containing known concentrations in 9:1 mixtures of 0.05 M HEPES 
buffer and DMSO at pH values 6.95 and 8.59 and in a 9:1 mixture of acetone and DMSO. 
The values of  were the same within experimental error in all three media, the average 
being 21 000 M-1 cm-1. Extinction coefficients of the product at 390 and 486 nm were de-
termined in “aged” reaction mixtures and assuming that nitrocefin is completely convert-
ed to its hydrolysis product. The values are 7 585 M-1cm-1 and 16 000 M-1cm-1 at 390 and 
486 nm, respectively. Stock solutions of the complexes, nitrocefin, and the inhibitor (sodi-
um succinate and sodium acetate) were prepared in the appropriate solvent and used im-
mediately to avoid possible decomposition. The concentrations of stock solutions of com-
plex and nitrocefin were 0.010 M each. The concentrations of the stock solutions of the in-
hibitors were varied and are specified in each particular experiment. Unless stated other-
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wise, the concentration of [Zn2L1(-NO3)(NO3)2] in kinetic studies was 5.0 x 10-4 M. In a 
typical kinetic run all the reagents were mixed in a spectrophotometric cell and allowed to 
equilibrate for 2 min inside the temperature-controlled UV-visible spectrophotometer be-
fore data collection began. Data were usually collected at 390 nm, the wavelength that cor-
responds to the maximum absorbance of nitrocefin. Because the reaction product also ab-
sorbs at 390 nm (P = 7 585 M-1cm-1), the extinction coefficient of nitrocefin was corrected, 
as shown in eqs 7-9, to account for product absorbance.  In the equations, AT, AS, and AP 
are the total, substrate, and pro- 
                 AT = AS + AP = S cS + P cP (7) 
                 ∆AT = ∆AS + ∆AP =  AS(f) – AS(i) + AP(f) – AP(i) S {cS(f) – cS(i)} 
+ 
                 P cP(f) = S {cS(f) – cS(i)} + P{cS(i) – cS(f)} = {S – P}{cS(f) – cS(i)} 
(8) 
                 cS(f) – cS(i) = 
AT
 S  P  (9) 
duct absorbances at a given wavelength; S and P are the extinction coefficients of the sub-
strate and the product at a given wavelength; cS and cP are the concentrations of the sub-
strate and the product at a given time; and c(f) and c(i) stand for final and initial concentra-
tions. Data were collected only during the first 3-5% of conversion in each reaction to 
avoid significant changes in the concentrations of the starting materials. The observed rate 
constants were then determined from the initial rates, the known concentration of the sub-
strates, and the corrected extinction coefficient of nitrocefin at 390 nm. The rate constants 
for the formation (kform) and dissappearance (kdis) of the anionic intermediate were ob-
tained by fitting experimental data to eq 10, where At is the absorbance at 640 nm and a  
At = a {exp(-kformt)-exp(-kdist)} (10) 
is kform[N]0/(kdis-kform) ([N]0 – initial concentration of nitrocefin). Nitrocefin and hydro-
lyzed nitrocefin do not absorb at 640 nm. 
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Results and Discussion 
 Preparation of Ligands and Complexes.  The dinucleating ligands HL1 and HL2 
(Scheme 2), derived from 2,4,6-trisubstituted phenol, provide an environment for two 
zinc(II) ions that resembles those in the active sites of the three metallo--lactamases de-
picted in Scheme 1. Two zinc(II) ions at the active sites are coordinated predominantly by 
histidine residues[Concha, 1996 #14; Fabiane, 1998 #15; Ullah, 1998 #13] and are bridged 
by a hydroxide ion postulated to serve as the nucleophile in hydrolysis. The bridging 
phenolate and the restricted separation between the two ethylenediamine arms in these 
ligands strongly favor the formation of dimetallic complexes.[Sorrell, 1985 #29; Mallah, 
1986 #30; Eduok, 1984 #31] Although several copper(II) and manganese(II) complexes of 
ligands in this class, including HL1, have been synthesized and employed as biomimetic 
models,[Sorrell, 1985 #29; Mallah, 1986 #30; Eduok, 1984 #31; Nasir, 1992 #32] only a few 
phenolate-bridged dizinc(II) complexes are known. Included is a dizinc(II) complex hav-
ing four methoxyethyl chelating arms.[Uhlenbrock, 1992 #33; Sakiyama, 1999 #34] In the 
present study, four novel dizinc(II) complexes of HL1 and HL2, [Zn2L1(-NO3)NO3)2], 
[Zn2L1(-OMe)(NO3)], [Zn2L2(NO3)3], and [Zn2L1(-OH)(NO3)2] were prepared and charac-
terized by X-ray crystallography. The first three were also characterized in solution by 1H 
NMR spectroscopy. 
 Structural Studies.  The structures of [Zn2L1(-NO3)(NO3)2], [Zn2L1(-OMe)(NO3)2], 
[Zn2L2(NO3)3], and [Zn2L1(-OH)(NO3)2] are presented in Figure 1 and selected bond 
lengths and angles are provided in Table 2. The complexes [Zn2L1(-NO3)(NO3)2], 
[Zn2L1(-OMe)(NO3)2], and [Zn2L1(-OH)(NO3)2] have similar structures. Each zinc(II) ion 
has a distorted octahedral environment with a bidentate nitrate serving as the terminal 
ligand. The C2 symmetry along the phenoxide-4-methyl axis in [Zn2L1(-OH)(NO3)2] com-
plex leads to identical coordination spheres of the two zinc atoms. The presence of the two 
bridging groups in each complex, the phenolate oxygen and either a hydroxide, 
methoxide, or nitrate ion, results in relatively short ZnZn distances of 3.115, 3.109, and 
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3.294 Å, respectively. The bridging ligand and terminal nitrate ion occupy coordination 
positions cis to one another. The chirality at N2 and N2A in [Zn2L1(-OH)(NO3)2] and at 
N3 and N2 in [Zn2L1(-OMe)(NO3)2] and [Zn2L1(-NO3)(NO3)2] could, in principle, result 
in the formation of the four diastereoisomers for each complex. The solid-state structures 
revealed the formation of only RR and SS isomers in each case.  
 The asymmetric complex [Zn2L2(NO3)3] contains two zinc(II) ions, Zn1 and Zn2, 
having distorted octahedral and distorted tetrahedral environments, respectively. The 
most striking feature of this complex is its lack of an exogenous bridging group; it there-
fore has a longer ZnZn distance compared to the other three compounds, 3.394(3) Å.  
 Solution Structures. The structures of [Zn2L1(-NO3)(NO3)2] and [Zn2L2(NO3)3] in 
solution were investigated by 1H NMR spectroscopy. The resonances of the two methylene 
groups in HL1 appear as a singlet for the free ligand. Upon binding to zinc(II), the  and  
protons in each methylene group undergo chemical shift changes and become 
inequivalent. Two pairs of methylene proton resonances occur for [Zn2L1(-NO3)(NO3)2] in 
aqueous solution, one as well-resolved doublets at 4.25 and 3.32 ppm and the other as 
broad peaks at 4.00 and 3.60 ppm. We assign the former to the NMR-equivalent RR and SS 
isomers based upon the following two findings. First, [Zn2L1(-NO3)(NO3)2], [Zn2L1(-
OH)(NO3)2], and the analogous methoxide complex [Zn2L1(-OMe)(NO3)2] exist as RR and  
SS isomers in  the  solid  state.[Kaminskaia, 1999 #36]  Second,  the latter  complex  dis-
solved in chloroform exhibits  and   
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proton resonances at chemical shifts of 4.45 and 3.25 ppm that are very similar to the well-
resolved resonances of [Zn2L1(-NO3)(NO3)2] in water. The broad pair of resonances is ten-
tatively assigned to NMR-indistinguishable SR and RS isomers. The exchange of the exog-
enous ligands is not expected to affect the chemical shifts of H and H.  
In 1H NMR titration experiments, a solution of the ligand was placed in an NMR 
tube to which the corresponding titrating solution that contained aliquots of 
Zn(NO3)2.6H2O and LiOH.H2O was added in a stepwise manner, as described in the Ex-
perimental Section. The concentrations of the free and bound ligand after each addition 
were determined by integrating the respective resonances. The experimental titration 
curve for HL1 is depicted in Figure 2. 
The signals in the 1H NMR spectrum of [Zn2L2(NO3)3] are rather broad in aqueous 
DMSO. The H and H resonances of the methylene groups in HL2 shift upon coordina-
tion, but partial overlap with the HDO resonance and the breadth of the line precluded 
their accurate integration. Instead, we followed the change upon titration in chemical shift 
at 3.79 ppm, which corresponds to the pyridine methylene group. The magnitude of this 
change is directly proportional to the concentration of the complex. The corresponding ti-
tration curve is shown in Figure S5. 
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The concentrations of the bound ligands grow with the stepwise addition of the ti-
trating solution that provides Zn(II) ions and base. Notably, in each case the concentration 
of the bound ligand is not further altered once the ratio [Zn(NO3)2]/[ligand] reaches the 
value of 2. This result indicates that both complexes exist as stable dimetallic species in the 
presence of water. The sigmoidal curve in Figure 2 is diagnostic of a cooperative interac-
tion between the two Zn(II)-binding sites in HL1; that is, binding of one Zn(II) ion affects 
the binding of the second. In this case, the binding of the first Zn(II) ion increases the affin-
ity of HL1 for the additional Zn(II) ion; the binding is positively cooperative. Ligand HL2 
does not exhibit cooperative binding of Zn(II), as Figure S5 clearly indicates. Diluting 
aqueous solutions of [Zn2L1(-NO3)(NO3)2] and [Zn2L2(NO3)3] to 5 x 10-4 M did not result 
in the dissociation of zinc(II) because the number and positions of the 1H resonances in 
NMR spectra remain the same.  
Ligand protonation constants (Kn), zinc(II) complexation constant (KZn2L), and 
deprotonation constants for the zinc(II) complex (Kph, Ka1, Ka2) were determined by po-
tentiometric pH titrations of HL13HBr in the presence and absence of Zn(NO3)2·6H2O, 
as described in the Experimental Section. Typical titration curves for HL13HBr are 
shown in Figure S6(A). The mixed protonation constants for the ligand logK1-logK3 are 
11.5 ± 0.1, 8.9 ± 0.1, and 6.4 ± 0.1, and agree with the literature values.[Kimura, 1994 
#72][Molenveld, 1999 #73][Kimura, 1995 #74] The titration curve in the presence of 2 
equiv of Zn(NO3)2·6H2O reveals the formation of a stable complex at pH > 6.3. Complex 
formation (logKZn2L = 14.23 ± 0.10) is accompanied by the deprotonation of the phenolic 
group (pKph = 6.43 ± 0.10) and an aqua ligand (pKa1 = 7.6 ± 0.1). The value pKph agrees 
well reported constants for the deprotonation of M(II)-bound phenol.[Kimura, 1987 #76] 
Deprotonation of the second aqua ligand (pKa2 = 11.2 ± 0.1) occurs when 6 equiv of 
NaOH are added. Only the dinuclear species were observed under the experimental 
conditions, as shown in Figure S6(B). Therefore, binding of the two zinc(II) ions to HL1 
is nearly simultaneous. Such highly cooperative binding of two zinc(II) ions is known 
for a binucleating octaazacryptand ligand.[Koike, 1996 #77] 
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Acid Dissociation Constants for the Aqua Ligands.  The formation of the coordi-
nated hydroxide at physiological pH is important for efficient metallohydrolase activity 
because this species often serves as a general base or nucleophile. The complex [Zn2L1(-
NO3)(NO3)2] does not contain coordinated water in the solid state (Fig 1). The coordinated 
nitrates are replaced by aqua ligands upon dissolution in the presence of water. The com-
plex [Zn2L1(-OH)(NO3)2], containing bridging hydroxide, was co-crystallized as a minor 
product together with [Zn2L1(-NO3)(NO3)2]. The pKa value of 7.6  0.1,[Martell, 1988 #28] 
determined by titration (Figure S6(A)), is assigned to the bridging water in [Zn2L1(-
OH2)(NO3)n(sol)2-n](2-n)+. Terminally bound water would have much higher pKa val-
ue.[Bazzicalupi, 1999 #78][Kimura, 1995 #74] The corresponding dissociation constant for 
[Zn(cyclen)(H2O)]2+ is 7.9.[Koike, 1994 #38] Bridging water is more acidic than terminally 
bound water because it interacts simultaneously with two zinc(II) ions. An even greater 
diminution in pKa would probably have occurred were it not for the compensating charge 
of the phenolate bridge in the L1 ligand. The finding that the bridging water in the 
dinuclear complex can be deprotonated at physiological pH is consistent with its postulat-
ed role as the relevant nucleophile in metallohydrolases.  
 The complex [Zn2L2(NO3)3] has no aqua ligands in the solid state (Fig. 1). Upon dis-
solution in water, one or more nitrate ligands are solvated. The pKa value of 8.15  0.15 for 
coordinated water in this complex is tentatively assigned to a terminally bound water 
molecule.  
Effect of Zinc Complexes on Nitrocefin Hydrolysis. Nitrocefin was chosen as the 
hydrolysis substrate because its hydrolytic reactions (eq 11) can be conveniently followed 
by UV-visible spectrophotometry.[O'Callaghan, 1972 #39]  This compound is one  of sev-
eral related cephalospo- 
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(11) 
rins and undergoes a distinctive color change upon hydrolysis by -lactamases. Nitrocefin 
absorbs at 390 nm ( = 21,000 M-1 cm-1). Its absorbance maximum and high extinction coef-
ficient are independent of solvent composition and pH within the range 6.95-8.59. This in-
tense visible absorbance is attributed to the dinitrostyrene substituent in the six-membered 
ring, resulting in a bathochromic shift due to the conjugation involving the dinitrostyryl 
group, the -lactam ring, and the double bond in the dihydrothiazine ring. Upon hydroly-
sis, the absorbance maximum shifts to 486 nm ( = 16,000 M-1 cm-1) owing to formation of 
the corresponding cephalosporanoic acid, as shown in eq 11. 
All three dizinc complexes catalyze the hydrolysis of nitrocefin in a similar manner, 
as revealed by the results in Table 3. The dinuclear complexes in Table 3 are 2 - 10 times 
more reactive than Zn(NO3)2. The complexes [Zn2L1(-OMe)(NO3)2] and [Zn2L1(-
NO3)(NO3)2]  convert to [Zn2L1(-OH)(NO3)2] in aqueous solution, as the 1H NMR data 
indicate (Experimental Section). Therefore, the reactivities of the two complexes are 
similar. Because the two Zn(II) ions at the active sites of -lactamases are bridged by a hy-
droxide ion, the catalytic precursor [Zn2L1(-NO3)(NO3)2] was chosen for further mecha-
nistic studies. As Figure 3 indicates, this complex catalyzes the hydrolysis of nitrocefin 
without forming any observable intermediates.  
Binding of -Lactam Substrates to Zn(II) complexes. -Lactam antibiotics can bind 
to transition metals via their carboxylate, sulfur atom, -lactam amide, and terminal amide 
moieties.[Grochowski, 1991 #65; Asso, 1984 #66] The mode of binding depends strongly 
on the metal ion and substrate. It has been suggested that penicillins coordinate via the -
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lactam nitrogen atom and the carboxylate group, whereas cephalosporins use the -lactam 
oxygen atom for binding.[Gensmantel, 1978 #41; Page, 1984 #42] 
The absorbance maximum and extinction coefficient of nitrocefin are unaffected 
upon binding to various Zn(II) salts and complexes. 1H NMR spectroscopy is also not very 
sensitive to -lactam coordination of metal complexes. The binding and equilibrium con-
stants therefore cannot be deduced on the basis of UV-visible spectrophotometry and 1H 
NMR experiments. On the other hand, the 13C NMR (160-180 ppm) and infrared (1600-
1800 cm-1) spectra of -lactam carbonyl groups are very sensitive to metal coordina-
tion.[Mondelli, 1977 #51; Scutaru, 1991 #54] As the data presented here indicate, addition 
of [Zn2L1(-NO3)(NO3)2] to a solution of penicillin G shifts the 13C resonance of the carbox-
ylate group from 171.7 ppm to 174.2 ppm. The positions of the other resonances do not 
change significantly. The downfield shift of the carboxylate 13C resonance is characteristic 
of metal ion coordination.[Kaminskaia, 1997 #43] Infrared spectral data reveal that addi-
tion of [Zn2L1(-NO3)(NO3)2] to penicillin G in DMSO solution causes 17 and 10 cm-1 shifts 
of the as(COO) and (C(O)--lactam) maxima, respectively. The blue shift and the position 
of as(COO-) at 1638 cm-1 are consistent with monodentate coordination of the carboxylate 
group to zinc(II).[Ferrer, 1997 #52; Zevaco, 1998 #53; Kupka, 1997 #55] The blue shift in 
(C(O)--lactam), moreover, reinforces this assignment by eliminating the possibility that 
coordination occurs via the oxygen atom of this moiety.[Anacona, 1999 #49; Kupka, 1997 
#55] Coordination by the -lactam nitrogen atom would result in a much higher blue shift 
than experimentally observed.[Woon, 1993 #56] The small change in (C(O)--lactam) pre-
sumably results from inductive effects originating from zinc binding to the carboxylate 
group.[Kupka, 1997 #55] The mononuclear zinc complexes Zn(bpta)(NO3)2 and 
Zn(cyclen)(OTf)2 bind to penicillin G only via their carboxylate groups, as clearly evi-
denced by the 13C NMR data in the Experimental Section.  
Penicillin G and nitrocefin, which were used in binding and kinetic experiments, re-
spectively, differ somewhat in structure (Scheme S2). We therefore investigated the bind-
ing of cephalothin, a nitrocefin-like substrate, by 13C NMR and IR spectroscopy. Addition 
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of [Zn2L1(-NO3)(NO3)2] to a cephalothin solution in DMSO causes a downfield shift of the 
carboxylic resonance at 163.4 ppm, a clear indication that its carboxylate group binds to 
zinc(II). The 2-ppm downfield shift of the lactamic carbonyl 13C resonance might suggest 
coordination by the -lactam oxygen, but the IR data rule out this possibility. The blue 
shift and position of as(COO) at 1630 cm-1 are consistent with monodentate carboxylate 
binding to zinc(II). Experiments with Zn(bpta)(NO3)2 and Zn(cyclen)(NO3)2 yield similar 
results. Mixing aqueous solutions of [Zn2L1(-NO3)(NO3)2] and cephalothin results in 
immidiate appearance of the white precipitate [Zn2L1(cephalothin)(NO3)2] that was iso-
lated. Its 13C NMR spectrum in DMSO-d6 is identical to that obtained by mixing the 
complex and cephalothin directly in DMSO solution. Therefore, cephalothin coordi-
nates to [Zn2L1(-NO3)(NO3)2] via the carboxylate group both in water and DMSO. 
In summary, penicillin G and cephalothin bind to [Zn2L1(-NO3)(NO3)2] and the 
mononuclear zinc(II) complexes only by means of a monodentate carboxylate group.  
Rate Law for the Hydrolysis of Nitrocefin.  Hydrolysis effected by [Zn2L1(-
NO3)(NO3)2] follows first-order kinetics with respect to the concentration of nitrocefin, as 
shown in Figure 5. The hydrolysis reaction also increases with [Zn2L1(-NO3)(NO3)2 in a 
9:1 water and DMSO mixture (Figure 5), but this dependence is not linear. This behavior 
could arise from one of two mechanisms, depicted in Scheme 3, both of which involve 
coordination of nitrocefin to the dizinc(II) complex. Coordinated nitrocefin is then at-
tacked by external water (Scheme 3A) and by zinc(II)-bound hydroxide (Scheme 3B) in 
bimolecular and unimolecular hydrolyses, respectively. Bimolecular hydrolysis 
(Scheme 3C), that is analogous to the hydrolysis of penicillin catalyzed by 
[Zn(cyclen)(OH)]+ in aqueous solution,[Koike, 1994 #38] can be ruled out because it re-
quires first order kinetic with respect to the complex. Fitting the experimental data in 
Figure 5 to eq 12 obtained for Scheme 3B yields a binding constant of 107  20 M-1 in the 
9:1 mixture of 0.05 M buffer and DMSO at pH 7.50. Water competes with a variety of 
substrates for binding to transition metal com- 
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k obs  Kk 2[Zn 2L]K[Zn 2L] 1  (12) 
plexes.[Kaminskaia, 1997 #43] In the absence of water, the binding of penicillin G and 
cephalothin to [Zn2L1(-NO3)(NO3)2] is much stronger and can be directly observed by 13C 
NMR and IR spectroscopy. Therefore, we carried out the hydrolytic reaction in a 1:9 mix-
ture of DMSO and acetone that contained small concentrations of water. As expected, the 
substrate binds more tightly to [Zn2L1(-NO3)(NO3)2] in this organic solvent, resulting in 
the saturation kinetics plots depicted in Figure 6. The experimental data were fit to eq 12, 
derived for Scheme 3A under the condition that [Zn2L] >>[N]. This fit afforded the bind-
ing constant (K) values of (3.1  0.5) x 104, (2.7  0.5) x 104, (1.5  0.4) x 10-4, and (1.7  0.5) 
x 10-4 M-1 at 0.112, 0.278, 0.556, and 1.112 M H2O, respectively.  
In conclusion, the kinetic and the binding studies in an organic solvent rule out the 
mechanism in Scheme 3C for the hydrolysis of nitrocefin catalyzed by [Zn2L1(-
NO3)(NO3)2]. 
 Effect of Water Concentration on the Hydrolysis Rate. The hydrolysis of nitrocefin 
was investigated at 0.112, 0.278, 0.556, and 1.112 M H2O as a function of the complex con-
centration (Figure 6). The respective microscopic rate constants, k2, (2.5  0.4) x 10-3, (2.8  
0.4) x 10-3, (2.3  0.4) x 10-3, and (3.5  0.5) x 10-3 min-1 indicate that hydrolysis of nitrocefin 
is not affected significantly by changes in water concentrations in organic solvent. This 
finding supports a mechanism in which zinc(II)-bound hydroxide attacks the coordinated 
substrate (Scheme 3B). Notably the value of k2 is lower in aprotic organic solvent con-
taining small concetrations of water than that in aqueous solution (Figures 5 and 6). 
This difference might be attributed to decreased ability of the mixed organic solvent to 
participate in stabilizing hydrogen bonding interactions with anionic transition 
state.[Catrina, 1999 #80] 
Effect of pH on Hydrolysis Rate.  The complex [Zn2L1(-NO3)(NO3)2] hydrolyzes 
nitrocefin more efficiently at higher pH values, as shown in Figure 7. This finding is con-
sistent with rate-limiting nucleophilic attack of the hydroxo species on the substrate, fol-
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lowed by fast protonation of the intermediate to give the hydrolysis product and regener-
ated catalyst. The nucleophilicity increases in the order Zn2L-OH2 < OH2 < Zn2L-OH < 
OH-. At high pH, the concentration of the more active Zn2L-OH species is elevated and the 
hydrolysis is fast.  
The  experimental  results for [Zn2L1(-NO3)(NO3)2] were fit to eq 13, derived for 
the 
kobs  =
k     [H +] +   k    Ka
Ka   +   [H
+]
OHH 2O
 
(13) 
mechanism in Scheme 4. The fit yielded a pKa value of 7.5  0.2 for the hydrolytically ac-
tive species. This value is identical to the pKa value of 7.4  0.1 for the bridging water in 
[Zn2L1(-OH2)(NO3)n(H2O)2-n](2-n)+ obtained by potentiometric titration experiments. 
Therefore, the bridging hydroxide in this complex acts as the nucleophile in nitrocefin hy-
drolysis. The respective observed rate constants for the aqua and hydroxo complexes are 
1.0 x 10-3 and 1.0 x 10-2 min-1, respectively. The hydroxo complex is only 10 times more 
reactive than the aqua complex presumably because the nucleophilicity of -OH is di-
minished by binding to two zinc(II) ions simultaneously. 
 Inhibition.  Acetate ion inhibits zinc(II)-catalyzed hydrolysis of nitrocefin (Figure 
8A). The inhibition of [Zn2L1(-NO3)(NO3)2] is best described by the mechanism in Scheme 
5 involving formation of the less reactive catalyst upon acetate coordination. Fitting the 
experimental data in Figure 8 to eq 14, where [I] is the acetate concentration, yielded a va- 
kobs =
k     +   k         K 2[I]
1   +   K2[I]
Zn 2L-IZn 2L
[Zn 2L]0
 
(14) 
lue of 139  46 M-1 for K2. Notably, the apparent binding constant for acetate is similar to 
that for nitrocefin. This finding corroborates the 13C NMR and IR data on substrate coordi-
nation to [Zn2L1(-NO3)(NO3)2]. The observed rate constants for the hydrolysis by the cata-
lyst and the inhibited catalyst are (5.9  0.2) x 10-3 and (1.1  0.1) x 10-3 min-1, respectively. 
Sodium succinate is an efficient inhibitor for [Zn2L1(-NO3)(NO3)2], as illustrated in 
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Figure 8B. Fitting the experimental data to eq 14 yielded values of 1143  260 M-1, (6.0  
0.1) x 10-3, and (4.5  0.1) x 10-4 min-1 for the succinate binding constant, and the rate con-
stants for the hydrolysis by catalyst and the inhibited catalyst, respectively. A low-
quality X-ray crystal structure reveals that each succinate binds to two Zn(II) ions from dif-
ferent molecules forming an extended, polymer-like structure. Notably, two succinate 
molecules actually displace the bridging nitrate or hydroxide that serves as the nucleo-
phile in nitrocefin hydrolysis. Such destruction of the catalyst would explain the low reac-
tivity of [Zn2L1(-NO3)(NO3)2] in the presence of succinate.  
 Temperature Effects.  Because the observed rate constant in aqueous solution is a 
composite quantity of at least two steps, substrate binding and hydrolysis, the activation 
parameters obtained from the temperature dependence plots are also composites. On the 
other hand, the rate constant in the organic solvent is a microscopic rate constant that cor-
responds to the hydrolysis of coordinated nitrocefin because nitrocefin is almost entirely 
bound in the presence of an excess of the catalyst. The zinc(II)-catalyzed hydrolysis of 
nitrocefin exhibits linear Eyring plot in organic solvent, as shown in Figure 9. A fit of the 
data to the Eyring equation yielded H≠ and S≠ values of 88.4  5.3 kJ M-1 and –45.3  
16.0 J M-1 K-1, respectively. The enthalpy of activation is higher than those obtained for the 
hydrolyses of penicillin G promoted by OH- and the mononuclear complex 
[Zn(cyclen)(OH)]+.[Koike, 1994 #38] The much more positive S≠ for the hydrolysis by 
[Zn2L1(-NO3)(NO3)2] supports a mechanism involving intramolecular attack by the bridg-
ing hydroxide as the rate-limiting step in nitrocefin hydrolysis. 
 Role of the Carboxylate.  The carboxylate group is "conserved" among -lactam an-
tibiotics and proposed to orient the substrate at the active site. 13C NMR data reveal that, 
in simpler model systems, the carboxylate group is always coordinated to zinc(II). Remov-
al of this coordinating anchor by methylation results in significantly decreased rates of hy-
drolysis of the -lactam amide bond. Thus, in the presence of [Zn2L1(-NO3)(NO3)2], peni-
cillin G methyl ester is hydrolyzed at least 103 times more slowly than penicillin G. Their 
respective rate constants are 5.1 and <0.007 M-1 min-1. A similar effect is observed in reac-
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tions catalyzed by Zn(NO3)2.  
 Solvent Isotope Effect. Nucleophilic attack of water or hydroxide at the -lactam 
carbonyl carbon must be followed by protonation of the amide nitrogen. The relative rates 
of these two sequential reactions determine the rate-limiting step and, ultimately, the fac-
tors that affect the overall reaction. Thus, the increased rate of hydrolysis at high pH and 
the absence of observable intermediates in aqueous solution are inconsistent with protona-
tion in the rate-limiting step. The effect of solvent isotope composition on hydrolysis was 
investigated to elucidate further the mechanism. Hydrolytic reactions of nitrocefin in H2O 
and D2O were studied by UV-visible spectrophotometry. Upon dissolution in D2O, the 
complex [Zn2L1(-NO3)(NO3)2] will most likely incorporate deuterium into the bridging 
hydroxide, so the reactivities of Zn2-OH and Zn2-OD can be compared. When [H+] = [D+] 
in a reaction mixture (pH = pD = 7.57), the solvent isotope effect, kH/kD, was measured to 
be 0.46. When [OH-] = [OD-] (pOH = pOD = 7.4), the solvent isotope effect was 0.204. The-
se results indicate that the Zn(II)-catalyzed hydrolysis of nitrocefin is characterized by a 
relatively large inverse isotope effect. Free OD- is 20-40% more reactive as a nucleophile 
than free OH-.[Jencks, 1987 #47] Presumably Zn(II)-coordinated OD- is also more reactive 
than Zn(II)-coordinated OH-. Our findings are therefore consistent with rate-limiting 
nucleophilic attack of hydroxide at the substrate, followed by fast protonation. 
 Formation of the Intermediate.  Zinc(II)-catalyzed hydrolysis of nitrocefin in 1:9 
mixtures of DMSO and water occurs without the formation of observable intermedi-
ates, as shown in Figure 3, presumably because their formation is slower than 
disssapearance. On the contrary, anionic intermediate (Scheme 1) at 665 nm was report-
ed for the enzymatic hydrolysis by metallo--lactamase.[Wang, 1999 #67][Wang, 1998 
#68] This species is bound to the enzyme via a zinc(II)-acyl linkage and a negatively 
charged nitrogen leaving group. It was concluded that electrostatic interaction between 
the negatively charged intermediate and the positively charged dinuclear zinc(II) center 
of the enzyme is important for stabilization because addition of exogenous ligands ac-
celerated collapse of the intermediate.[Wang, 1999 #67] Decreasing water content in the 
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hydrolysis reaction catalyzed by [Zn2L1(-NO3)(NO3)2] to 20% results in appearance of a 
new species with absorbance maximum at 640 nm (Figure 10). This species slowly con-
verts to hydrolyzed nitrocefin, as evident from characteristic absorbance of the latter at 
490 nm. This conversion becomes nearly instanteneous (t1/2 < 0.2 s) upon the addition of 
acids such as CF3COOH and CH3COOH. These findings are consistent with the for-
mation of the anionic intermediate in the model system. The rate constants for the in-
termediate formation and dissappearance at 333 K were obtained by fitting the experi-
mental data in Figure S7 to eq 10. Their respective values are 0.25 and 0.006 min-1 at 2.78 
M H2O, and 0.09 and 0.03 min-1 at 27.8 M H2O. Formation rate constant is diminished 
2.5-fold at 27.8 M H2O because water inhibits binding of nitrocefin to the dizinc(II) 
complex. On the contrary, dissappearance rate constant is increased 5-fold at 27.8 M 
H2O because water readily displaces the intermediate from the dizinc(II) complex. Free 
anionic intermediate is unstable and upon protonation converts to hydrolyzed 
nitrocefin. Increasing water content further results in diminishing the concetration of 
the intermediate to unobservable levels in aqueous solution. 
 The Mechanism of the Catalytic Hydrolysis. A mechanism of nitrocefin hydrolysis 
catalyzed by [Zn2L1(-NO3)(NO3)2] that is consistent with the foregoing results is dis-
played in Scheme 6. The first step is coordination of the -lactam carboxylic group to one 
of the Zn(II) ions. Such binding orients the -lactam carbonyl carbon and bridging hydrox-
ide in a favorable position for the nucleophilic attack. Although zinc(II) coordination to 
the -lactam oxygen was not detected for the substrate, it cannot be rule out for the tran-
sition state. The slightly negative value of S≠ seems to support this conclusion. In 
aqueous solution the rate-limiting attack of the bridging hydroxide at the coordinated sub-
strate is followed by fast protonation of the intermediate, then by product release. Slower 
protonation step in aqueous DMSO results in accumulation of the anionic intermediate. 
The complex [Zn2L1(-NO3)(NO3)2] is the true catalyst precursor, because it hydrolyzes at 
least 10 equiv of nitrocefin, (Figure S8, Supplementary Information). Product inhibition 
was not detected, presumably because the binding constant is low in aqueous solution.  
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 Nitrocefin Hydrolysis by Mononuclear Complexes. The two mononuclear com-
plexes Zn(cyclen)(NO3)2 and Zn(bpta)(NO3)2 efficiently hydrolyze nitrocefin in aqueous 
solution, as Table 3 reveals. The aqua ligand in the former complex has a pKa value of 7.9. 
[Koike, 1994 #38] The pH-dependence for hydrolysis by Zn(bpta)(NO3)2, shown in Figure 
S9, yields a pKa value of 7.84  0.2 for the aqua ligand. These two pKa values compare well 
with those of the dinuclear complexes and are sufficiently low for zinc(II)-bound hydrox-
ide to form at physiological pH. The hydrolysis of nitrocefin catalyzed by Zn(bpta)(NO3)2 
follows first-order kinetics with respect to the complex at low concentrations of the com-
plex (Figure S10). Nitrocefin coordination to Zn(bpta)(NO3)2 causes a leveling off at higher 
concentrations of complex. Fitting the experimental data to eq 12 yielded values for the 
binding (K) and rate (k2) constants of 2461 M-1 and 7.1 x 10-3 min-1, respectively, at pH 6.95. 
Nitrocefin binds more strongly to [Zn(bpta)(H2O)2]2+ than to [Zn2L1(-NO3)(NO3)2] pre-
sumably because zinc(II) is less electrophilic in the dinuclear complex that contains 
negatively charged phenolate ligand. The effect of the complex concetration on kobs at 
13.9 and 27.8 M H2O and pH 7.50 is shown in Figure S11. Fitting the experimental data 
to eq 12 gave k2 values of 0.17 and 0.18 min-1 at 13.9 and 27.8 M H2O, respectively. Inde-
pendence of hydrolysis of bound nitrocefin on water concetration suggests 
intramolecular attack by zinc(II)-bound hydroxide. Consequently, the mechanism for 
Zn(bpta)(NO3)2 is similar to that for [Zn2L1(-NO3)(NO3)2] and involves initial binding of 
the substrate followed by intramolecular hydrolysis by the coordinated hydroxide 
(Scheme S3). The complex [Zn(cyclen)(H2O)]2+ has fewer coordination sites available for 
nitrocefin binding and nucleophile activation, and, therefore effects hydrolysis 
bimolecularly according to Scheme 3C. 
 
Conclusions and Prospects 
 We have demonstrated that the bridging hydroxide in the dinuclear zinc(II) com-
plex acts as the nucleophile in hydrolysis of -lactams and that the carboxylate group of 
these antibiotics is used for favorable positioning of the substrate and the nucleophile. 
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Therefore, the present model studies support main steps in the suggested mechanism of 
metallo--lactamases. The model complexes, however, lack many active site residues, 
such as Asp90, that are available metallo--lactamase. Hence, their activity is inferior to 
that of the enzymes. Mononuclear Zn(II) complexes are as efficient in nitrocefin hydroly-
sis as the dinuclear Zn(II) complexes. Based on kinetic analyses of various metallo--
lactamases (Table S17), the effect of the second Zn(II) ion on the hydrolysis rate remains 
controversial.[Paul-Soto, 1998 #17; Paul-Soto, 1999 #61; Bounaga, 1998 #62] The addition 
of the second Zn(II) ion to the active site results in marginal improvement in -lactam hy-
drolysis for some cases or inhibition in others. Taken together these two findings indicate 
that the role of the second Zn(II) ion in -lactamases is most likely structural or regulatory. 
There is no mechanistic advantage in having two Zn(II) ions instead of one for -lactam 
hydrolysis. 
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activity.  
 
References 
  
30
 
  
31
 
Table 1.  Summary of X-ray Crystallographic Data 
 
 [Zn2L1-NO3)(NO3)2] [Zn2L1-OMe)(NO3)2] [Zn2L2(NO3)3] [Zn2L1-
OH)(NO3)2] 
formula C19H35N7O10Zn2 C20H38N6O8Zn2 C20H28BrN7O10Zn
2 
C19H36N6O8Zn2 
fw 652.28 621.30 737.14 607.28 
cryst. system tetragonal monoclinic monoclinic monoclinic 
space group P421c P21/c P21/c C2/c 
a, Å 25.0187(3) 10.4432(4) 8.64890(10) 14.017(5) 
b, Å  8.7916(4) 17.2821(2) 11.416(5) 
c, Å 8.6641(2) 29.4646(12) 19.5061(5) 16.931(5) 
, deg  97.298(1) 97.583(1) 111.462(5) 
V, Å3 5423.17(16) 2683.30(19) 2890.10(9) 2521.4(16) 
Z 8 4 4 4 
T, K 188(2) 188(2) 188(2) 188(2) 
calc, g cm-3 1.598 1.538 1.694 1.600 
(Mo K), mm-1 1.833 1.841 3.104 1.957 
2 range, deg 3-57 4-57 3-56 5-57 
total no. of data 33564 16394 17769 7739 
no. of unique 
data 
6443 6257 6646 2930 
no. of obsd. dataa 4653 4193 5790 2131 
no of params 350 333 418 168 
R  b 0.0409 0.0433 0.0381 0.0353 
wR2 c 0.0772 0.1209 0.1384 0.0942 
 
 aObserved criterion: I > 2 (I).  bR = ||F0| – |Fc||/|F0|.  cwR2= {  [w  ( F02 – Fc2)2/[w(F02)2]}1/2  
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Table 2.  Selected Interatomic Distances (Å) and Angles (deg) for the Complexesa 
 
Complex Bond lengths Bond angles 
[Zn2L1(-NO3)(NO3)2] Zn(1)Zn(2)           3.2942(6) 
Zn(1)-O(1)               2.040(3) 
Zn(2)-O(1)               2.070(3) 
Zn(1)-O(5)               2.148(3) 
Zn(2)-O(5)               2.126(3) 
Zn(1)-N(1)               2.121(3) 
Zn(1)-N(2)               2.125(3) 
 
Zn(1)-O(1)-Zn(2)             106.5(1) 
Zn(1)-O(10)-Zn(2)           100.9(1) 
O(1)-Zn(1)-N(1)               105.8(1) 
O(1)-Zn(1)-N(2)                94.6(1) 
O(1)-Zn(1)-O(10)              76.3(1) 
[Zn2L1(-OMe)(NO3)2] Zn(1)Zn(2)          3.1093(6) 
Zn(1)-O(5)              1.968(3) 
Zn(2)-O(5)              1.973(3) 
Zn(1)-O(1)              2.052(2) 
Zn(2)-O(1)              2.063(2) 
Zn(1)-N(1)              2.131(3) 
Zn(1)-N(2)              2.169(3) 
 
Zn(1)-O(5)-Zn(2)           104.20(12) 
Zn(1)-O(1)-Zn(2)             98.16(10) 
O(1)-Zn(1)-N(1)             102.90(12) 
O(1)-Zn(1)-N(2)               88.78(11) 
O(1)-Zn(1)-O(5)               79.01(10) 
[Zn2L2(NO3)3] Zn(1)Zn(2)             3.394(3) 
Zn(1)-N(1)               2.090(3) 
Zn(1)-N(2)               2.059(2) 
Zn(1)-O(1)               2.036(2) 
Zn(2)-N(6)               2.070(3) 
Zn(2)-N(3)               2.132(3) 
Zn(2)-O(1)               1.939(2) 
Zn(1)-O(1)-Zn(2)           117.30(10) 
O(1)-Zn(1)-N(1)             171.96(10) 
O(1)-Zn(1)-N(2)               91.20(9) 
O(1)-Zn(2)-N(6)             132.75(12) 
O(1)-Zn(2)-N(3)               93.29(10) 
N(3)-Zn(2)-N(6)               86.83(11) 
[Zn2L1(-OH)(NO3)2] Zn(1)Zn(1A)        3.1147(10) 
Zn(1)-O(1)               1.954(3) 
Zn(1)-N(1)               2.145(3) 
Zn(1)-N(2)               2.135(3) 
Zn(1)-O(5)               2.061(2) 
 
Zn(1)-O(1)-Zn(1A)        105.69(19) 
Zn(1)-O(5)-Zn(1A)          98.18(12) 
O(1)-Zn(1)-N(2)             166.62(11) 
O(1)-Zn(1)-N(1)             103.56(8) 
O(1)-Zn(1)-O(5)               78.07(12) 
aNumbers in parentheses are estimated standard deviations of the last significant figure. 
Atoms are labeled as indicated in Fig. 1 and Figs. S1-S4 
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Table 3.  Reactivities of Various Complexes in the Hydrolysis of Nitrocefina 
 
Complex  103kobs, min-1 
none < 0.07 
[Zn2L1(-NO3)(NO3)2]  6.0 
[Zn2L1(-OMe)(NO3)2]  3.2 
[Zn2L2(NO3)3] 13.7 
Zn(NO3)2   1.3 
Zn(cyclen)(OTf)2   2.8 
Zn(bpta)(OTf)2   7.2 
 
a T, 312.5 K; solvent, 1:9 mixture of DMSO:H2O at pH 7.50 (adjusted with 0.05 M HEPES 
buffer); initial concentrations of nitrocefin and a complex = 3.75 x 10-5 and 5.00 x 10-4 M, 
respectively; concentration of Zn(NO3)2 = 5.00 x 10-4 M.b  
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Scheme 1. Kaminskaia, Spingler, and Lippard 
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Scheme 2.  Kaminskaia, Spingler, and Lippard 
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Scheme 3.  Kaminskaia, Spingler, and Lippard 
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Scheme 4.  Kaminskaia, Spingler, and Lippard 
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Scheme 5.  Kaminskaia, Spingler, and Lippard 
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Scheme 6.  Kaminskaia, Spingler, and Lippard 
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Figure Captions 
Figure 1.  ORTEP diagrams of [Zn2L1(-NO3)(NO3)2 ], [Zn2L1(-OMe)(NO3)2], 
[Zn2L2(NO3)3], 
                   and [Zn2L1(-OH)(NO3)2 ] showing the 50%, 30%, 50%, and 30% probability 
                   thermal ellipsoids for all nonhydrogen atoms, respectively.  
Figure 2.  Product formation in titration experiments of HL1 with Zn(NO3)2.6H2O 
                  and LiOH.H2O followed by 1H NMR spectroscopy. 
Figure 3.  Hydrolysis of nitrocefin in a 1:9 mixture of DMSO:0.05 M HEPES 
                   buffer at pH 7.50 followed by UV-visible experiments in the presence of  
                   [Zn2L1(-NO3)(NO3)2].  
Figure 4.  Effect of nitrocefin concentration on its catalytic decomposition by [Zn2L1(- 
                  NO3)(NO3)2]. 
Figure 5.  Effect of [Zn2L1(-NO3)(NO3)2] concentration on nitrocefin hydrolysis  
                  in aqueous solution. 
Figure 6.  Effect of [Zn2L1(-NO3)(NO3)2] concentration on nitrocefin hydrolysis  
                  in organic solvent in the presence of 0.112 (), 0.278(), 0.556 (), and  
                  1,12 () M H2O. 
Figure 7.  Effect of the solution pH value on nitrocefin hydrolysis catalyzed by [Zn2L1(- 
                  NO3)(NO3)2]. The rate constants were corrected for the 
                   background hydrolysis. 
Figure 8.  Effect of sodium acetate (A) and sodium succinate (B) concentrations on  
                  nitrocefin hydrolysis catalyzed by [Zn2L1(-NO3)(NO3)2]. 
Figure 9.  Effect of temperature on nitrocefin hydrolysis catalyzed by [Zn2L1(- 
                    NO3)(NO3)2] in organic solution. The concentration of the complex in  
                    was 9.4 x 10-4 M. 
Figure 10.  Formation of the intermediate at 640 nm after 1 (), 10 (), 20 (), 30 (),  
                   40 (), and 60 () min. The solvent was a 1:4 mixture of 0.05 M HEPES buffer 
                   and DMSO, the temperature was 313 K. The initial concetrations of  
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                    [Zn2L1(-NO3)(NO3)2]  and nitrocefin were 5.0 x 10-4 and 3.8 x 10-5 M.  
                    respectively.  
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Figure 1. Kaminskaia, Spingler, and Lippard 
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Figure 2. Kaminskaia, Spingler, and Lippard  
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 Figure 3.  Kaminskaia, Spingler, and and Lippard  
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 Figure 4.  Kaminskaia, Spingler, and Lippard  
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Figure 5.  Kaminskaia, Spingler, and Lippard  
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Figure 6.  Kaminskaia, Spingler, and Lippard  
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Figure 7.  Kaminskaia, Spingler, and Lippard  
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 Figure 8.  Kaminskaia, Spingler, and Lippard  
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Figure 9.  Kaminskaia, Spingler, and Lippard  
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Figure 10.  Kaminskaia, Spingler, and Lippard 
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